Peran Ethanol Extract Propolis sebagai terapi penunjang pada mencit yang diinfeksi dengan Mycobacterium tuberculosis
Abstract
Abstrak. Tuberkulosis masih menjadi penyakit infeksi yang serius di dunia. Menurut laporan WHO, penyakit ini menginfeksi sepertiga penduduk dunia. Menyebabkan 2 juta kematian tiap tahun dan hampir 8 juts penderita baru. Beberapa tahun terakhir jugs dilaporkan adanya peningkatan kuman tuberkulosis yang tahan terhadap obat anti tuberkulosis (MDR-TB). Pada sisi lain, sejak 50 tahun yang lalu beluro ditemukan adanya obat anti tuberkulosis baru, Riset ini dilakukan dalam rangka untuk memberikan pandangan baru terhadap peran imunomodulator alami (EEP) sebagai obat penunjang dalam pengobatan tuberkulosis. 100 ekor mencit dikelompokkan menjadi grup 5 dan grup 12. Tiap grup dipisahkan lagi menjadi 5 kelompok yang lebih kecil yaitu grup control, EEPlOO, 200, 400 dan 800. Mencit kemudian diinfeksi dengan Mycobacterium tuberculosis intranasal. 4 minggu kemudian semua mencit diberi isoniazid 25 mg/kgBB per oral .. grup EEP diberi EEP per oral l 00, 200, 400 dan 800 mglkgBB sesuai grupnya, sedang grup kontrol tidak. Pada minggu ke 5 semua mencit grup S diterminasi dengan jalan pemberian eter overdosis dan grup 12 diterminasi pada minggu ke 12 dengan cara yang sama, Paru-paru mencit diambil secara aseptic untuk dilakukan pemeriksaan histopatologi. Untuk konfirmasi perbedaan antara perlakuan dan kontrol digunakan uji annova dan uji T dengan p<0,05. Basil pada grup 5 dan 12 memperlihatkan bahwa EEP dapat menurunkan kerusakan jaringan paru, skor Dorman untuk kontrol, EEPIOO, 200, 400 dan 800 mg/kgBB berturut-turut adalah 13,55; 10,05; 9,3; 8,65 dan 11,45 untuk grup 5 sedang untuk grup 12 berturut-turut adalah 18,l; 14; 11,7;10,1 dan 9,4. Sebagai kesimpulan kami laporkan bahwa EEP dapat mengurangi kerusakan jaringan paru pada mencit yang diinfeksi dengan
Mycobacterium tuberculosis. (JKS 2009;2:6.S-70)
Kata kunci : Mycobacterium tuberculosis, EEP, IFN--y, lung damage.
Abstract. Tuberculosis still the leading infection disease in the world. According to WHO report, it affected almost one thirth people in the world. It caused 2 millions death anually and almost 8 millions new people infected with this bacteria every year. In the last years, it has been reported that multidrug resistent
Mycobacterium tuberculosis (MDR-TB) have increased. On the other band. since SO years ago no new drug for tuberculosis have been reported. This research conducted to give a new view of natural immunomoduJator
(ethanol extract propolis/EEP) as an adjuvant therapy for tuberculosis. Hundred mice separated into two groups, group S and 12. Each group separated again into 5 small groups, control, EEP 100, EEP 200, EEP 400 and EEP
800. Mice infected with Mycobacterium tuberculosis intranasal. 4 weeks later, they were given isoniazid 25
mg/kgBW orally. The EEP's groups were given ·EEP 100, 200, 400 and 800 mg/kgBW respectively but the control groups were not. At the end of S 'th week, all mice in groups S were terminated by overetherisatioo and group 12 were terminated at the end of 12'th weeks. Mice lung were separated aseptically, examination of histopathologic were done as described on methodology. We used the Anova and T test to confirm the differentiation between control and EEP's groups with p<0,05. In group 5 and 12 the result showed that EEP could reduce lung damaged, Dormans scores for control, EEP 100, 200, 400 and 800 mg/kgBW respectively were 13,55; 10,05; 9,3; 8,65 and 11,45 for group 5, and 18,1; 14; 11,7;10,l and 9,4 for group 12. In summary we reported that EEP could reduce the lung damages do to Mycobacterium tuberculosis. (JKS 2009;2:65-70)
Key word: Mycobacterium tuberculosis,EEP, IFN-y,lung damage
Keywords
Full Text:
PDFReferences
Daftar Pustaka
Dye C, Scheele S, Dolin P, Pathania V, Reviglione
MC. 1999. Global Burden of Tuberculosis, Estimated
Incidence, Prevalence, and Mortality by Country.
JAMA 282: 677-686.
WHO. 2004. Global Tuberculosis Control
Surveillance,Planning, Financing. WHO REPORT.
Ignatia ML, Handojo I, 1997. Perbandingan nilai
diagnostik uji Mycodot dan uji PAP-TB untuk
diagnosis tuberkulosis paru. Media /DI vol 22 no.4
hat 16-20.
Depkes. 2003. Penyakit Malaria dan TBC
menyebabkan 170.000 kematian setiap tahun di
Indonesia.
http://www.dC17kes SQ.id/index.php?option=news&ta
sk=view article&sid..,52&Itemid=2
Mendez AP, Raviglione MC, Laszlo A, Bink:in N,
Rieder Hl., Bustreo F, Cohn DL, Weezenbeek CSBL,
Kim SJ, Chaulet P, Nun P. 1998. Global surveillance for antituberculosis-drug resistance,1994-1997.
NEJM'.338:1641-9.
Long R. 2000. Drug-Resistant Tuberculosis.
CMAJ: 163(4):425-8.
Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, Hoffner S, Rieder Hl., Binkin N,
Dye C, Williams R, Raviglione MC. 2000. Global Trends In Resistance to Antituberculosis Drugs. NEJM: 344:1294-303.
Tomioka H. 2004. Adjunctive Immunotherapy of Mycobacterial Infections. Current Pharmaceutical Design 10: 3297-3312.
Othieno C, Hirsch CS, Hamilton BD, Wilkinson I<.,
Ellner JJ, Toossi AZ. 1999. Interaction of
Mycobacterium tuberculosis-Induced Transforming
Growth Factor bl and lnterleukin-10. Infection And
Immunity, Vol. 67, No. 11 P. 5730-5735
Han S, Sung KH, Yim D, LeeS, oe K, Lee CK, Ha NJ,
Kim K 2002. Activation of Murine Macrophage Cell
Line RAW 264.7 by Korean Propolis. Arch Pham Res
Vot 25, No 6, 895-902.
Orsolic N, Basic I. 2003. Immunomodulation by water-soluble derivative of propolis: a factor of antitumor reactivity. Journal of Ethnopharmacology
: 265-273.
Sa-Nunes A, Faccioli LH, Sforcin JM. 2003.
Propolis: lymphocyte proliferation and IFN-y
production Journal of Ethnophannacology87: 93-
Saunders BM, Cheers C. 1996. Intranasal Infection of Beige Mice with Mycobacterium avium Complex: Role of Neutropbils and Natural Killer Cells. InjectionAnd Immunity 64: 10: 4236-4241.
Saunders Blf, Frank AA, Orme Ilvf, Cooper AM.
Interieuk.in-6 Induces Early Gamma Interferon Production in the lnf ected Lung but ls Not Required for Generation of Specific Immunity to Mycobacterium tuberculosis Infection. Infection And Immunity 68: 6: 3322-3326.
Dormans J, Burger M, Aguilar D, Hemandez-pando R. Kremer K, Roholl P, M. Arend S & Van Soolingen D. 2004. Correlation of virulence, lung pathology, bacterial load and delayed t'j1)t,
hypersensitivity responses after infection with different Mycobacteriumtuberculosis genotypes in a BALB/c mouse model. Clin Exp lmmunol 137 :460-
.468
Khan AE, Kimerling :ME. 2005. Chemotherapy of tuberculosis. In : Tuberculosis and Nomuberculosis Mycobacterial Injection, 2th ed.. Mc Graw-Hill. Medical Publishing Division, pp77-90.
Raja A. 2004. Immunology oftuberculosis. Indian J
MedRes 120: 213-232.
Robinson BWS, McLemore TL, Crystal RG. 1985.
Gamma Interferon Is Spontaneously Released By
Alveolar Macrophages And Lung T Lymphocytes1n
Patients With Pulmonary Sarcoidosis. The Journal of
Cltnical Investigation. 15: 1488-1495.
Refbacks
- There are currently no refbacks.
Copyright© 1987-2017 | ISSN: 1412-1026 | EISSN: 2550-0112
Jurnal Kedokteran Syiah Kuala is licensed under a Creative Commons Attribution 4.0 International License.
Published by:
Fakultas Kedokteran, Universitas Syiah Kuala
Jl. Tgk. Tanoh Abee, Kopelma Darussalam,
Banda Aceh, 23111, Indonesia.
Phone: +626517551843
Email: jks@unsyiah.ac.id
Online Submissions & Guidelines | Editorial Policies | Contact | Statistics | Indexing | Citations